Viewing Study NCT00129935

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:35 PM

Ignite Modification Date: 2025-12-28 @ 7:15 AM

Study NCT ID: NCT00129935

Status: COMPLETED

Last Update Posted: 2023-03-31

First Post: 2005-08-11

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

Sponsor: Spanish Breast Cancer Research Group

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module